New hope for those with age-related macular degeneration
Acuity Medical has successfully completed the U.S. Food and Drug Administration (F.D.A.) complied clinical trial of its TheraMac device. This would treat dry age-related macular degeneration (A.M.D.). Prior to the F.D.A. trial, an open label study was conducted on 404 patients.

Facebook comments